BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roessler HI, Knoers NVAM, van Haelst MM, van Haaften G. Drug Repurposing for Rare Diseases. Trends Pharmacol Sci 2021;42:255-67. [PMID: 33563480 DOI: 10.1016/j.tips.2021.01.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Benchoua A, Lasbareilles M, Tournois J. Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders. Cells 2021;10:3290. [PMID: 34943799 DOI: 10.3390/cells10123290] [Reference Citation Analysis]
2 Challa AP, Zaleski NM, Jerome RN, Lavieri RR, Shirey-Rice JK, Barnado A, Lindsell CJ, Aronoff DM, Crofford LJ, Harris RC, Alp Ikizler T, Mayer IA, Holroyd KJ, Pulley JM. Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases. Front Genet 2021;12:707836. [PMID: 34394194 DOI: 10.3389/fgene.2021.707836] [Reference Citation Analysis]
3 Zheng Y, Wu Z. Cascade Deep Forest With Heterogeneous Similarity Measures for Drug-Target Interaction Prediction. Front Genet 2021;12:702259. [PMID: 34504515 DOI: 10.3389/fgene.2021.702259] [Reference Citation Analysis]
4 Klaassen K, Djordjevic M, Skakic A, Kecman B, Drmanac R, Pavlovic S, Stojiljkovic M. Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier. Mol Genet Metab Rep 2021;29:100822. [PMID: 34900593 DOI: 10.1016/j.ymgmr.2021.100822] [Reference Citation Analysis]
5 Yang L, Yang C, Wang L, Yang Z, Guo D, Fan C. Repurposing Old Drugs as Novel Inhibitors of Human MIF from Structural and Functional Analysis. Bioorg Med Chem Lett 2021;:128445. [PMID: 34758374 DOI: 10.1016/j.bmcl.2021.128445] [Reference Citation Analysis]
6 Ohmoto A, Fuji S. Current status of drug repositioning in hematology. Expert Rev Hematol 2021;:1-7. [PMID: 34657533 DOI: 10.1080/17474086.2021.1995348] [Reference Citation Analysis]
7 Tieu JH, Sahasrabudhe SA, Orchard PJ, Cloyd JC, Kartha RV. Translational and clinical pharmacology considerations in drug repurposing for X-linked adrenoleukodystrophy-A rare peroxisomal disorder. Br J Clin Pharmacol 2021. [PMID: 34558098 DOI: 10.1111/bcp.15090] [Reference Citation Analysis]
8 Parolo S, Tomasoni D, Bora P, Ramponi A, Kaddi C, Azer K, Domenici E, Neves-Zaph S, Lombardo R. Reconstruction of the Cytokine Signaling in Lysosomal Storage Diseases by Literature Mining and Network Analysis. Front Cell Dev Biol 2021;9:703489. [PMID: 34490253 DOI: 10.3389/fcell.2021.703489] [Reference Citation Analysis]
9 Kringel D, Malkusch S, Lötsch J. Drugs and Epigenetic Molecular Functions. A Pharmacological Data Scientometric Analysis. Int J Mol Sci 2021;22:7250. [PMID: 34298869 DOI: 10.3390/ijms22147250] [Reference Citation Analysis]